stockrowFortrea Holdings Inc.
FTRE Healthcare Biotechnology
Fortrea Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 1.00% from fiscal 2024.
- Revenue
- −1.40%
- EPS
- +103.7%
- Free cash flow
- −34.0%
- Total debt
- −6.33%
Quarter to September 2026, against a year earlier
Follow FTRE
Alert me
Fortrea Holdings Inc. (FTRE) Operating cash flow
Fortrea Holdings Inc.'s operating cash flow for fiscal 2025 was $113.5M, down 56.8% from $262.8M in fiscal 2024. Over the twelve months to 30 September 2026 it was $201.8M. Over the past ten years it has ranged from $82.7M (fiscal 2022) to $262.8M (fiscal 2024); the current reading is higher than 33% of that period. Fortrea Holdings Inc. ranks 20th of 603 Biotechnology companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $113.5M | (56.81%) |
| FY2024 | $262.8M | 56.06% |
| FY2023 | $168.4M | 103.63% |
| FY2022 | $82.7M | (51.30%) |
| FY2021 | $169.8M | (15.48%) |
| FY2020 | $200.9M | — |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | $60.8M | 110.38% |
| Jun 2026 | $28.9M | — |
| Mar 2026 | −$17.0M | — |
| Dec 2025 | $129.1M | 48.73% |
| 15 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| HRMY Harmony Biosciences Holdings, Inc. compare | $323.0M |
| FTRE Fortrea Holdings Inc. | $201.8M |
| SRPT Sarepta Therapeutics, Inc. compare | $185.6M |
| TRAX First Tracks Biotherapeutics, Inc. compare | −$112.2M |
| ZYME Zymeworks Inc. compare | −$119.3M |
| VIR Vir Biotechnology, Inc. compare | −$141.0M |
| IMNM Immunome, Inc. compare | −$208.8M |
| REPL Replimune Group, Inc. compare | −$245.5M |
| BHVN Biohaven Ltd. compare | −$472.5M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item